Fig. 3From: Laboratory monitoring of rivaroxaban in Chinese patients with deep venous thrombosis: a preliminary studyCorrelation between plasma concentration of rivaroxaban and PT (a), aPTT (b) or anti-factor Xa activity (c)Back to article page